Jacobs Levy Equity Management, Inc Illumina, Inc. Transaction History

Jacobs Levy Equity Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$101.05 - $133.57 $20.2 Million - $26.7 Million	-199,591 Reduced 40.14%	297,683 $31.1 Million
Q1 2024 May 15, 2024	BUY	$127.73 - $147.2 $10.4 Million - $12 Million	81,378 Added 19.57%	497,274 $68.3 Million
Q4 2023 Feb 14, 2024	BUY	$92.79 - $142.53 $36.8 Million - $56.5 Million	396,059 Added 1996.57%	415,896 $57.9 Million
Q3 2023 Nov 16, 2023	BUY	$128.91 - $192.44 $2.56 Million - $3.82 Million	19,837 New	19,837 $2.72 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.